ORLADEYO caps 150 mg 28 pce

7680684640018 CH-68464 B06AC06 02.99.0.

Reimbursement limitations:

ORLADEYO

Après garantie de prise en charge des coûts par l’assureur-maladie et consultation préalable du médecin-conseil.

ORLADEYO caps 150 mg 28 pce
ORLADEYO caps 150 mg 28 pce
ORLADEYO caps 150 mg 28 pce
1 / 3
google

Details

Product number
6846401
CPT
-
Packaging group
28
Unit
Hartkapseln
Composition
berotralstatum 150 mg ut berotralstati dihydrochloridum, amylum pregelificatum, crospovidonum, silica colloidalis anhydrica, magnesii stearas, Kapselhülle: gelatina, E 171, E 132, E 172 (nigrum), E 172 (rubrum), Drucktinte: lacca, propylenglycolum, kalii hydroxidum, E 172 (nigrum), pro capsula.

Articles (1)

Orladeyo 150 mg, Hartkapseln
Hartkapseln
28
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
04/06/2025
Professional SmPC
Français
04/06/2025
Professional SmPC
Italien
04/06/2025
Patient information leaflet
Allemand
12/03/2025
Patient information leaflet
Français
12/03/2025
Patient information leaflet
Italien
12/03/2025

Detailed composition

Substance Quantity Type Category
(N/A)
150.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK
(N/A)
- Substance FIMDK
(N/A)
- Substance FTODK
(N/A)
- Substance FTODK
(N/A)
- Substance HNIDK
(N/A)
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
(N/A)
- Substance HNIDK
(N/A)
- Substance FTODK

Reimbursement information

Public price
CHF 13396.10
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/07/2022

Authorization holder

BioCryst Schweiz GmbH

6300 ZUG

Authorization information

Swissmedic authorization number
68464
Drug name
Orladeyo, Hartkapseln
Galenic form
KAHA
ATC Code
B06AC06
Authorization status
Z
Dispensation category
B
First authorization
07/06/2022
Authorization expiration date
06/06/2027
IT number
02.99.0.
Domain
Human medicine
Field of application
Hereditäres Angioödem

Packaging details

Description (FR)
ORLADEYO caps 150 mg 28 pce
Description (DE)
ORLADEYO Kaps 150 mg 28 Stk
Market launch
07/06/2022
Narcotic (BTM)
No